TRUPTrupanion, Inc.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Trupanion’s second quarter results were met with a positive market response, reflecting better-than-expected revenue growth and robust core business execution. Management identified an acceleration in pet enrollments, driven by enhancements to the customer enrollment experience and expanded deductible and coinsurance options. CEO Margi Tooth pointed to "improved web conversion" and "solid performance" from the company’s updated products as key contributors to net subscription pet growth, which r

Record adjusted operating income and margin expansion highlight strong pet insurance growth.

Accident and health insurers face medical-cost pressures, but stronger underwriting, technology adoption and demand for supplemental coverage support growth.

Trupanion (TRUP) is back in focus after reporting second quarter 2026 earnings, issuing updated full year guidance, and unveiling a new integration agreement with veterinary software provider Digitail. See our latest analysis for Trupanion. Trupanion's second quarter 2026 results, updated guidance and the Digitail integration have arrived after a choppy year for the stock. The share price has fallen 27.45% year to date and the 1 year total shareholder return is down 44.7%, while the 3 month...

Earlier this week, Trupanion reported second-quarter 2026 results showing lower net income year over year but stronger first-half profitability, updated its 2026 guidance with expected total revenue of about US$1.58–US$1.60 billion and subscription revenue of roughly US$1.12–US$1.13 billion, and highlighted continued double‑digit subscription growth. The company also unveiled an integration with veterinary software provider Digitail to embed its Veterinary Portal and VetDirect Pay tools...

Trupanion's Q2 earnings beat estimates as revenue rose 11%, while premium valuation and muted analyst sentiment support a wait-and-see approach.

Moby summary of Trupanion, Inc.'s Q2 2026 earnings call

Trupanion (NASDAQ:TRUP) reported higher second-quarter revenue and adjusted operating income as the pet insurer benefited from increased subscription revenue, improved enrollment conversion and stable retention. The company also announced a $100 million share repurchase authorization and narrowed it

Subscription adjusted operating income surged 24% year-over-year, driven by accelerated pet growth and improved unit economics.

While the top- and bottom-line numbers for Trupanion (TRUP) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Trupanion (TRUP) delivered earnings and revenue surprises of +45.46% and +0.84%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Pet insurance provider Trupanion (NASDAQ:TRUP) announced better-than-expected revenue in Q2 CY2026, with sales up 11.1% year on year to $392.9 million. Its GAAP profit of $0.16 per share was 41.2% above analysts’ consensus estimates.

Lemonade (NYSE:LMND) reported second-quarter results marked by accelerating in-force premium growth, higher revenue and gross profit, and a narrower adjusted EBITDA loss, while reaffirming its expectation to reach positive adjusted EBITDA in the fourth quarter of 2026. Chief Executive Officer and C

Chubb (NYSE:CB) reported a strong second quarter of 2026, with Chairman and Chief Executive Officer Evan Greenberg pointing to underwriting performance, investment income, life insurance growth and global diversification as key contributors to results. Core operating earnings were $2.8 billion, or

Trupanion (TRUP) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

The average of price targets set by Wall Street analysts indicates a potential upside of 46.3% in Trupanion (TRUP). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Trupanion (TRUP) is back in focus after recent trading, with the stock last closing at $27.37 and showing mixed return patterns over the month and the past 3 months for pet insurance investors to assess. See our latest analysis for Trupanion. Recent trading has been volatile for Trupanion, with a 15.73% 1 month share price return and a 4.23% 3 month share price return, while the year to date share price return is down 26.42% and the 1 year total shareholder return has declined 46.19%. If you...

Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they struggle to grow or generate consistent profits, making them unattractive borrowers.